Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 5 results:
Author Title [ Type(Desc)] Year
Filters: Author is Mamas, M.  [Clear All Filters]
Journal Article
D. Yu, Peat, G., Jordan, K. P., Bailey, J., Prieto-Alhambra, D., Robinson, D. E., Strauss, V. Y., Walker-Bone, K., Silman, A., Mamas, M., Blackburn, S., Dent, S., Dunn, K., Judge, A., Protheroe, J., and Wilkie, R., Estimating the population health burden of musculoskeletal conditions using primary care electronic health records, Rheumatology (Oxford), 2021.
L. E. Clarson, Bajpai, R., Whittle, R., Belcher, J., A. Sultan, A., Kwok, C. S., Welsh, V., Mamas, M., and Mallen, C. D., Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction, Heart, 2020.
C. A. Lawson, Zaccardi, F., Squire, I., Okhai, H., Davies, M., Huang, W., Mamas, M., Lam, C. S. P., Khunti, K., and Kadam, U. T., Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity, Circ Heart Fail, vol. 13, p. e006472, 2020.
S. S. Zghebi, Rutter, M. K., Ashcroft, D. M., Salisbury, C., Mallen, C., Chew-Graham, C. A., Reeves, D., van Marwijk, H., Qureshi, N., Weng, S., Peek, N., Planner, C., Nowakowska, M., Mamas, M., and Kontopantelis, E., Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design, BMJ Open, vol. 8, p. e020926, 2018.
G. Nakafero, Grainge, M. J., Valdes, A. M., Townsend, N., Mallen, C., Zhang, W., Doherty, M., Mamas, M., and Abhishek, A., β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score matched cohort study, Rheumatology (Oxford), 2021.
[Page last reviewed 4 May 2021]